Grants and Contributions:

Back to search

Title:

SARS-CoV-2 Point of Care Test Development

Agreement Number:

Agreement Value:

$1,776,553.00

Agreement Date:

Jun 18, 2020 - Mar 31, 2023

Description:

This project is to develop and qualify a rapid Point-of-Care diagnostic test for the SARS-CoV-2 virus that causes Covid-19. The test will be run on a portable reader that will be capable of operating in a clinic or in the field using a battery power source.

Organization:

National Defence

Expected Results:

Aim is to strengthen the response to COVID-19, as well as future pandemics, through the development of strategies to re-use protective gear, clean equipment and workspaces, gain real-time insight for decision making, and care for front line workers.

Location:

Toronto, Ontario, CA

Reference Number:

180-2022-2023-Q3-R&D-001

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Type:

For-profit organization

Amendment Date

Oct 26, 2022

Recipient's Operating Name:

Custom Biologics

Recipient's Legal Name:

MJMG Holdings Inc

Program:

Innovation for Defence Excellence and Security Program - Innovation Networks

Program Purpose:

Collaborate with academic and private sector partners to build a network of expertise to support Canada’s current and future defence and security needs.

Amendments:

See Amendments